Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: A multicenter Australian study

Scandinavian Journal of Gastroenterology

Volumn 50, Issue 5, 2015, Pages 567-576

  Gory, Ilana ^a   Fink, Michael ^b   Bell, Sally ^c   Gow, Paul ^b   Nicoll, Amanda ^d   Knight, Virginia ^e   Dev, Anouk ^e   Rode, Anthony ^d   Bailey, Michael ^e   Cheung, Wa ^a   Kemp, William ^a   Roberts, Stuart K ^a  

^a ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

Hepatocellular carcinoma; Radiofrequency ablation; Surgical resection; Survival

Indexed keywords

CREATININE;

ADULT; ARTICLE; BILE LEAKAGE; CANCER RECURRENCE; CANCER SURGERY; CHILD PUGH SCORE; CREATININE BLOOD LEVEL; DEEP VEIN THROMBOSIS; DISEASE COURSE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MULTICENTER STUDY; OVERALL SURVIVAL; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; SUBPHRENIC ABSCESS; TREATMENT FAILURE; TUMOR VOLUME; WOUND DEHISCENCE; AGED; AUSTRALIA; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DIAGNOSIS; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; AUSTRALIA; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CONFIDENCE INTERVALS; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84925377997     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.953572     Document Type: Article

References (44)

1. Parkin DM, Bray F, Ferlay I, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-17.
3. Shariff MI, Cox U, Gomaa AI, Khan SA, Gedroyc W, Taylor-Robinson SD. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev Gastroenterol Hepatol 2009; 3:353-67.
4. El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340: 745-50.
5. Taylor-Robinson SD, Foster GR, Aora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK. 1979-94. Lancet 1997;350:1142-3.
6. Law M, Roberts SK, Dore GJ, Kaldor J. Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality. Med J Aust 2000;173:403-5.
7. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF Jr. International trends of primary liver cancer. Int J Cancer 2001;94:290-6.
8. Bruix J, Llovet JM. Major advancements in hepatocellular carcinoma. Lancet 2009;373:614-16.
9. Kemp W, Nguyen S, Bailey MJ, Pianko S, Roberts SK. Survival in hepatocellular carcinoma: impact of screening and aetiology of liver disease. J Gastro Hepatol 2005;20: 873-81.
10. Ikai I, Kudo M, Arii S, Omata M, Kojiro M, Sakamato M, et al. Report of the 18th follow up survey of primary liver cancer in Japan. Hepatol Res 2010;40:1043-59.
11. Bruix J, Sherman M; Practice guidelines committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42: 1208-36.
12. Llovet JM, Ducreux M, Lencioni R, Di Bisceglie AM, Galle PR, Dufour JF, et al. EASL-EORTC Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-43.
13. Marin-Hargreaves G, Azoulay D, Bismuth H. Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol 2003;47:13-27.
14. Borie F, Bouvier AM, Herrero A, Faivre J, Launoy G, Delafosse PO, et al. Treatment and prognosis of hepatocellular carcinoma: a population based study in France. J Surg Oncol 2008;98:505-9.
15. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati I, Tinelli C, et al. Sustained complete response and complication rates, after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 2008;47:82-9.
16. N'Kontchou G,Mahamoudi A, Mounir A, Ganne-Carrie N, Grando V, Coderc E, et al. Radiofrequency ablation of hepatocellular carcinoma: long term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009;50:1475-83.
17. Lencioni R, Allgaler H, Cloni D, Olschewski M, Deibert P, Crocetti L, et al. Randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235-40.
18. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, et al. A Randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122-30.
19. Cho Y, Kim J, Kim M, Han J. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009;49:453-70.
20. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005;54:1151-6.
21. Huang J, Yan L, Cheng Z, Wu H, Wang J, Xu Y, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010;252:903-12.
22. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006;243: 321328.
23. Feng K, Yan J, Li X, Xia F, Ma K, Wang S, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol 2012;57:794-802.
24. Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000;32:1224-9.
25. Vivarelli M, Guglielmi A, Ruzzenente A, Cucchetti A, Bellusci R, Cordiano C, et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 2004;240:102-7.
26. Hong SN, Lee SY, Choi MS, Lee JH, Koh KC, Paik SW, et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 2005;39:247-52.
27. Guglielmi A, Ruzzenente A, Valdegamberi A, Pachera S, Campagnaro T, D'Onofrio M, et al. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 2008;12:192-8.
28. Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi K, Yamamoto Y, et al. Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications. Hepatogastroenterology 2008;55:2171-4.
29. Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, et al. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 2009;16:359-66.
30. Huang J, Hernandez-Alejandro R, Croome KP, Yan L, Wu H, Chen Z, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics - a retrospective study of 1,061 cases. J Gastrointest Surg 2011;15:311-20.
31. Yun WK, Choi MS, Choi D, Rhim HC, Joh JW, Kim KH, et al. Superior longterm outcomes after surgery in Child-Pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation. Hepatol Int 2011;5:722-9.
32. Hung HH, Chiou YY, Hsia CY, Su CW, Chou YH, Chiang JH, et al. Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin Gastroenterol Hepatol 2011;9:79-86.
33. Wang JH, Wang CC, Hung CH, Chen CL, Lu SN. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol 2012;56:412-18.
34. Peng ZW, Lin XJ, Zhang YJ, Liang HH, Guo RP, Shi M, et al. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology 2012;262: 1022-33.
35. Pompili M, Saviano A, de Mattheis N, Cucchetti A, Ardito F, Federico B, et al. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma £3 cm. Results of a multicenter Italian survey. J Hepatol 2013;59:89-97.
36. Zhou Y, Zhao Y, Li B, Xu D, Yin Z, Xie F, et al. Metaanalysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 2010;10:78.
37. Li L, Zhang J, Liu X, Li X, Jiao B, Kang T. Clinical outcomes of radiofrequency ablation and surgical resection for small hepatocellular carcinoma: a metaanalysis. J Gastroenterol Hepatol 2012;27:51-8.
38. Cho YK, Kim JK, Kim WT, Chung JW. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology 2010;51:1284-90.
39. Deloitte Access Economics. The economic cost and health burden of liver diseases in Australia. GESA 2013.
40. Takayama T, Makuuchi M, Hasegawa K. Single HCC smaller than 2 cm: surgery or ablation?: surgeon's perspective. J Hepatobiliary Pancreat Sci 2010;17:422-4.
41. Ruzzenente A, Guglielmi A, Sandri M, Campagnaro T, Valdegamberi A, Conci S, et al. Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study. J Gastrointest Surg 2012;16:301-11.
42. Kao W-Y, Chiou Y-Y, Hung H-H, Chou Y-H, Su C-W, Wi J-C, et al. Risk factors for long term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio index. Eur J Gastroenterol Hepatol 2011;23:528-36.
43. Li W-H, Ma K-W, Cheng M, Chui K-H, Chan P-T, Chu W-H, et al. Radiofrequency ablation for hepatocellular carcinoma: a survival analysis of 117 patients. ANZ J Surg 2010;80:714-21.
44. Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 2012;107:569-77.